Publication | Open Access
Understanding <scp>COVID</scp>‐19 Risk in Patients With <scp>Immune‐Mediated</scp> Inflammatory Diseases: A <scp>Population‐Based</scp> Analysis of <scp>SARS</scp>–<scp>CoV</scp>‐2 Testing
13
Citations
34
References
2021
Year
Patients across all IMIDs were more likely to be tested for SARS-CoV-2 versus those without IMIDs. The risk of SARS-CoV-2 infection varied across disease subgroups.
| Year | Citations | |
|---|---|---|
Page 1
Page 1